Johnson & Johnson $JNJ delivered robust first-quarter results that exceeded Wall Street expectations, setting a positive tone for the company's overall financial performance. The reported revenue reached USD 21.89 billion, representing a 2.4% increase compared to the same quarter last year, surpassing forecasts of USD 21.56 billion. Adjusted earnings per share climbed to USD 2.77, up 2.2% year-over-year and outperforming analysts’ projections of USD 2.59.